Qualitek Labs issues EGM notice for ₹47 crore preferential issue
- Qualitek Labs scheduled EGM for October 16, 2026, to approve ₹47 crore preferential issue
- Equity shares priced at ₹518.55; warrants at ₹518.55 with 18-month tenor
- Remote e-voting window opens October 13, 2026, with cut-off date October 9, 2026
- Allottee Vibha Singhi replaced by Jagattaraini Tieup Private Limited for 16,000 shares

*this image is generated using AI for illustrative purposes only.
Qualitek Labs has issued the formal notice for an Extra-Ordinary General Meeting (EGM) scheduled for October 16, 2026, to seek shareholder approval for a preferential issue aggregating approximately ₹47 crore.
The Board of Directors convened on Tuesday, September 22, 2026, to evaluate and approve these capital infusion proposals under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The meeting commenced at 4:30 pm and concluded at 8:30 pm.
Preferential Issue Details
The company will issue up to 3,86,000 fully paid-up equity shares of face value ₹10 each at an issue price of ₹518.55 per share, including a premium of ₹508.55. This tranche aggregates to an amount up to ₹20,01,60,300.
Additionally, the board approved the issuance of up to 5,20,000 fully convertible warrants, each carrying the right to subscribe to one equity share. These warrants are also priced at ₹518.55 each, aggregating to an amount up to ₹26,96,46,000. The consideration for both instruments is cash.
| Instrument | Quantity | Issue Price (₹) | Total Amount (₹) | Category |
|---|---|---|---|---|
| Equity Shares | 3,86,000 | 518.55 | 20,01,60,300 | Promoter & Non-Promoter |
| Convertible Warrants | 5,20,000 | 518.55 | 26,96,46,000 | Promoter Group |
Allottee Structure and Substitution
The equity shares are proposed to be allotted to 26 investors, primarily in the non-promoter category, with Ashish Rameshchandra Kacholia receiving the largest allocation of 1,73,200 shares. Kamal Grover, a promoter, is allocated 1,200 shares.
The entire tranche of 5,20,000 warrants is proposed to be allotted to TIC Services Private Limited, which falls under the promoter group category. The warrants have a tenor of 18 months from the date of allotment. Subscription requires 25% payment at allotment, with the remaining 75% payable upon exercise.
In a subsequent development on September 23, 2026, the Preferential Issue Committee approved the substitution of one proposed allottee for equity shares. Vibha Singhi (Non-Promoter), originally allocated 16,000 shares, has been replaced by Jagattaraini Tieup Private Limited (Non-Promoter) for the same quantity of 16,000 shares. All other terms and conditions remain unchanged.
Shareholder Approval and Timeline
The preferential issues are subject to the approval of shareholders. The board decided to convene an Extra-Ordinary General Meeting on Friday, October 16, 2026, to seek this consent. The draft notice for the meeting has been approved.
EGM Logistics and Voting Schedule
The EGM will be held virtually through Video Conferencing/Other Audio-Visual Means at 12:30 pm. Pursuant to Section 108 of the Companies Act, 2013, members can cast votes via remote e-voting. The schedule for voting is as follows:
| Event | Date | Time |
|---|---|---|
| Cut-off date for eligibility | Friday, October 9, 2026 | - |
| Remote e-voting commences | Tuesday, October 13, 2026 | 9:00 am |
| Remote e-voting ends | Thursday, October 15, 2026 | 5:00 pm |
| EGM Date | Friday, October 16, 2026 | 12:30 pm |
Regulatory Compliance and Trading Window
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the exchange was notified of the meeting. A trading window remained closed for designated persons, including directors, promoters, and their immediate relatives, from September 17, 2026, until 48 hours after the conclusion of the board meeting, extending through September 24, 2026.
The notice of the meeting is available on the company’s website and the BSE portal. Antaryambhiksha, Managing Director, signed the intimation.
Historical Stock Returns for Qualitek Labs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.92% | -1.74% | +13.78% | +58.04% | +46.15% | +185.19% |
How will the ₹47 crore capital infusion specifically impact Qualitek Labs' operational expansion or debt reduction plans in the upcoming fiscal year?
What are the potential dilution effects on existing minority shareholders once the 5,20,000 convertible warrants held by the promoter group are fully exercised?
Will the significant allocation to Ashish Rameshchandra Kacholia signal a strategic partnership or influence future corporate governance decisions at Qualitek Labs?


































